Basal Insulin as a Foundational Strategy in T2D - Vivian Fonseca, MD, FRCP, Program Chair

Basal Insulin as a Foundational Strategy in T2D - Vivian Fonseca, MD, FRCP, Program Chair

The Evidence-Based Rationale for Optimizing HA1c Target Goal Attainment with Physiologic, Long-Acting Basal Insulin: Patient Targeting, Switching and Sequencing Strategies 


Published

Created by

CMEducation Resources symposium

Related Presenters

Vivian Fonseca, FRCP, MD

Vivian Fonseca, FRCP, MD

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine American Diabetes Association (ADA)